BME · BlackRock Health Sciences Trust
Market Cap
$586.88M
Shares
12.92M
Volume · Oct 20
38.32K
Avg daily vol (3M)
42.5K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$44.30
Open$43.89
Day$43.71–44.37
52W close$37.67–46.28
Avg vol 30d39K
Short int26K · 0.2% float · 1.0d
Short vol39%
DataJan 2020–Oct 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
7.1%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+17.6%
Trailing year
Short interest
0.2%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
−1%
below
RSI (14)
52
neutral
MACD trend
Positive
52-week position
77%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
+14%
trailing
YTD return
+8%
this year
Relative strength
+6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $45 › 200d $42 — 50d above 200d
Institutional flow
Distributing
12 of 79 funds reported for Sep 30 · net -1.1K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.20% of float · ▼ -24.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
79 holders — near 3-yr high, broad support
Squeeze score
29
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
14%
annualized · 1-yr
Max drawdown
−12%
past year
ATR
1.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
−1%
Neutral
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
77%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $45 › 200d $42 — 50d above 200d
Institutional flow
Distributing
12 of 79 funds reported for Sep 30 · net -1.1K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.20% of float · ▼ -24.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
79 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $38
Now $44 · 77%
Range high $46
vs 200-day avg +6%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BME
this stock
BlackRock Health Sciences Trust
|
$586.88M | +7.7% | — | — | 0.2% |
|
BLK
BlackRock, Inc.
|
$366.31B | +5.1% | +16.2% | 27.0 | 0.6% |
|
BN
BROOKFIELD Corp /ON/
|
$83.46B | -20.5% | — | — | 1.0% |
|
BX
Blackstone Inc.
|
$82.83B | -30.5% | +9.2% | 24.1 | 3.0% |
|
KKR
KKR & Co. Inc.
|
$78.09B | -31.8% | -11.0% | — | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BME | -0.1% | -0.5% | +13.9% | +0.4% | +7.7% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | +1.4% | +0.4% | +6.2% | -0.1% | -4.7% |
Capital returns
Latest dividend
$0.262
/ share · ex Oct 15, 2026
Declared · upcoming
$0.2621
/ share · ex Nov 13, 2026
Paid (TTM)
$3.144
/ share · 12 payouts
Dividend yield (TTM, derived)
7.10%
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.